Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

B4GALT2 anticorps (AA 155-271)

B4GALT2 Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7271198
  • Antigène Voir toutes B4GALT2 Anticorps
    B4GALT2 (UDP-Gal:betaGlcNAc beta 1,4- Galactosyltransferase, Polypeptide 2 (B4GALT2))
    Épitope
    • 11
    • 8
    • 7
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 155-271
    Reactivité
    • 37
    • 24
    • 6
    • 5
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 36
    • 1
    Lapin
    Clonalité
    • 37
    Polyclonal
    Conjugué
    • 16
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp B4GALT2 est non-conjugé
    Application
    • 24
    • 20
    • 3
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC)
    Fonction
    B4GALT2 Rabbit pAb
    Séquence
    PGVLMGGRYT PPDCTPAQTV AVIIPFRHRE HHLRYWLHYL HPILRRQRLR YGVYVINQHG EDTFNRAKLL NVGFLEALKE DAAYDCFIFS DVDLVPMDDR NLYRCGDQPR HFAIAMD
     Réactivité croisée
    Humain, Souris, Rat
    Attributs du produit
    Polyclonal Antibodies
    Purification
    Affinity purification
    Immunogène
    Recombinant fusion protein containing a sequence corresponding to amino acids 155-271 of human B4GALT2 (NP_085076.2).
    Isotype
    IgG
    Top Product
    Discover our top product B4GALT2 Anticorps primaire
  • Indications d'application
    WB,1:500 - 1:2000,IHC,1:100 - 1:200
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Avoid freeze / thaw cycles.
  • Antigène
    B4GALT2 (UDP-Gal:betaGlcNAc beta 1,4- Galactosyltransferase, Polypeptide 2 (B4GALT2))
    Autre désignation
    B4GALT2 (B4GALT2 Produits)
    Synonymes
    anticorps B4Gal-T2, anticorps B4Gal-T3, anticorps beta4Gal-T2, anticorps Ggtb2, anticorps b4gal-t1, anticorps b4galt2, anticorps beta4gal-t1, anticorps cdg2d, anticorps ggtb2, anticorps gt1, anticorps gtb, anticorps b4gal-t2, anticorps beta4gal-t2, anticorps b4Gal-T2, anticorps si:ch211-261p7.4, anticorps CKII, anticorps beta-1,4-galactosyltransferase 2, anticorps UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2, anticorps UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1, gene 2, anticorps UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 S homeolog, anticorps B4GALT2, anticorps B4galt2, anticorps b4galt1.2, anticorps b4galt2.S, anticorps b4galt2
    Sujet
    This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose, all transfer galactose in a beta1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. The enzyme encoded by this gene synthesizes N-acetyllactosamine in glycolipids and glycoproteins. Its substrate specificity is affected by alpha-lactalbumin but it is not expressed in lactating mammary tissue. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2011],B4Gal-T2,B4Gal-T3,beta4Gal-T2,B4GALT2,B4GALT2
    ID gène
    8704
    UniProt
    O60909
    Pathways
    Glycosaminoglycan Metabolic Process
Vous êtes ici: